🇺🇸 FDA
Patent

US 6391554

Detecting cancerous conditions by assaying for telomerase activity

expired A61KA61K31/70A61K38/00

Quick answer

US patent 6391554 (Detecting cancerous conditions by assaying for telomerase activity) held by Geron Corporation and Board of Regents expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Geron Corporation and Board of Regents
Grant date
Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/70, A61K38/00